Jin X, Deng Q, Ye S, Liu S, Fu Y, Liu Y, Wu G, Ouyang G, Wu T.
Theranostics. 2024 May 13;14(7):3014-3028. doi: 10.7150/thno.94207. eCollection 2024.
PMID:38773979
Role of CDKN2C Fluorescence In Situ Hybridization in the Management of Medullary Thyroid Carcinoma.
El Naofal M, Kim A, Yon HY, Baity M, Ming Z, Bui-Griffith J, Tang Z, Robinson M, Grubbs EG, Cote GJ, Hu P.
Ann Clin Lab Sci. 2017 Sep;47(5):523-528.
PMID:29066476
Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF.